ArticleCureus2025
Population-Based Evidence of Familial Clustering in Pulmonary Carcinoid Tumors: Insights From the Utah Population Database.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary carcinoid tumors are rare neuroendocrine neoplasms. While gastrointestinal carcinoids have established familial clustering, the heritable component of pulmonary carcinoids, particularly outside of multiple endocrine neoplasia type 1 (MEN1) syndrome, remains poorly defined. Utah's unique linked genealogy-cancer registry enables population-based assessment of familial risk.
methodsWe used the Utah Population Database (UPDB) linked to the Utah Cancer Registry (a Surveillance, Epidemiology, and End Results (SEER) registry) to identify individuals diagnosed with pulmonary carcinoid tumors (International Classification of Diseases for Oncology, Third Edition (ICD-O-3), histology codes 8240, 8249). The Genealogical Index of Familiality (GIF) test evaluated excess pairwise relatedness compared with 1,000 matched control sets. Relative risks (RRs) were estimated for first-, second-, and third-degree relatives, with expected cases based on cohort-specific incidence rates.
resultsA total of 232 pulmonary carcinoid cases with ≥3 generations of genealogy were identified. The GIF test demonstrated significant excess relatedness (GIF: 5.36 vs. 2.65; p=0.002), with excess in parent-offspring and avuncular pairs. RRs were significantly elevated for first-degree relatives (RR: 5.78; 95% CI: 1.03-18.21; p=0.048) and second-degree relatives (RR: 12.91; 95% CI: 6.42-23.29; p<0.0001), but not third-degree relatives. We identified 61 high-risk pedigrees with significantly more cases than expected. Incidence rates of pulmonary carcinoid were similar in Utah (0.8%) and the rest of SEER (0.7%), despite markedly lower overall lung cancer incidence in Utah.
conclusionsOur findings demonstrate the significant familial clustering of pulmonary carcinoid tumors in a large, population-based resource, supporting a potential heritable contribution independent of MEN1 syndrome. These results justify further genetic and environmental investigations in high-risk pedigrees to identify susceptibility loci and modifiable exposures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.